Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Gilead Sciences in the Drug Discovery & Development Pharma 50

Gilead Sciences

Rank: 15

2021 Rank: 13

Foster City, California, United States
www.gilead.com

2021 Revenues ($USD) : $27,305,000,000
2021 R&D spend : $5,363,000,000
2021 Number of Employees : 14,400
Fiscal Year End : 12/31/2021
Leader : CEO Daniel O’Day

Gilead Sciences became the first company to win FDA approval for a COVID-19 therapy with Veklury (remdesivir) on October 22, 2020. Strong sales of the drug in 2021 more than made up for the negative impact of COVID-19 on the company’s HIV and Hepatitis C drugs. The Forest City, California–based company announced in February 2022 that the drug maintained efficacy against omicron and other SARS-CoV-2 variants. Gilead won seven approvals or accelerated approvals in the U.S. and Europe in 2021. In 2021, the company completed its acquisition of MYR GmbH for approximately €1.45 billion. In 2020, the firm acquired the immune-oncology company Forty Seven for $4.9 billion. —BB

[A Gilead Sciences facility in La Verne, Calif. Image courtesy of Gilead.]

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE